LACOSAMIDE
NDC 70710-1359, Lacosamide, injection, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1359
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209465
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1359-6 | 70710135906 | 10 VIAL in 1 CARTON (70710-1359-6) / 20 mL in 1 VIAL (70710-1359-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/07356cf2-224b-40d2-b827-e10a6b42c232
Use it
Look up 70710-1359 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1359. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.